Insulet Corp revenue increases to $358.10 million in quarter ended Mar 31, 2023 from previous quarter
Key fundamental financials
profit of $23.80 million
Revenue of $358.10 million
earnings per share of $0.34
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$358.10 million
$23.80 million
profit
Sep 2022
$340.80 million
$5.20 million
loss
Jun 2022
$299.40 million
$35 million
loss
Insulet Corp [PODD] has reported $23.80 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.34 per share.
Revenue for the quarter was $358.10 million.
The Bedford, Massachusetts (MA)-based company operating in the surgical & medical instruments & apparatus sector has total shareholders equity of $502.80 million.